Creating Belonging through the Power of Language
By
After taking second place at the MIT $100K Entrepreneurship Competition Launch event in May, Inclusively.ai wants to make diversity, equity, inclusion, and belonging even more actionable.
By
After taking second place at the MIT $100K Entrepreneurship Competition Launch event in May, Inclusively.ai wants to make diversity, equity, inclusion, and belonging even more actionable.
Researchers at MIT Sloan have calculated the chances of catching coronavirus when aloft, though pandemic conditions keep shifting
By
Perrin Quarshie, MBA ’16, hoped to learn what pitfalls to avoid and how to make a sustainable career during the 2008 recession. What he found, though, would go far beyond his short-term future.
Our Identity + Inclusion Series are admissions events set to showcase the vibrant people at MIT Sloan. Interested in learning more? Find our recorded current students and alumni panels here!
MIT spinout Essmart has created a supply chain to help local retail shops in rural India sell life-improving products.
By
Yousaf Bajwa, MBA ’22, is an aerospace fanatic and a community builder on a mission to create inclusive spaces for people with FLI backgrounds at the school and beyond.
Christina Peña’s goal is to “innovate in the sphere of education.” Mission-driven with a passion for education technology, she arrived at MIT Sloan without a background in business, excited to dive into data analytics and entrepreneurship—and even start an EdTech venture of her own.
By
Tim Rowe, MBA ’95, spoke at the iLead Speaker Series in late March about how Cambridge Innovation Center (CIC) and CIC Health came to be.
By
When Coca-Cola Southwest Beverages wanted to use big data to measure the growth potential of their customers, they turned to Tico Han and Sydney Mo (both MBAn ’21) to help them develop an action plan.
By
Continuus Pharmaceuticals, a Massachusetts-based startup focused on making medicine affordable and accessible all over the world, turned to H-Lab for help developing an actionable distribution strategy for ICM-made pharmaceuticals.